Tianyin Pharmaceutical CO (TPIY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2011 | 03-2011 | 12-2010 | 09-2010 | 06-2010 | |
| Sales | 23,035 | 24,881 | 25,334 | 21,951 | 19,680 |
| Cost of Goods | 13,514 | 14,045 | 14,000 | 11,140 | 9,575 |
| Gross Profit | 9,521 | 10,836 | 11,334 | 10,811 | 10,106 |
| Operating Expenses | 6,888 | 5,848 | 7,006 | 6,385 | 5,430 |
| Operating Income | 3,147 | 5,033 | 5,328 | 4,566 | 5,251 |
| Interest Expense | -52 | 30 | 22 | 120 | 60 |
| Other Income | -56 | 378 | 1,583 | -144 | -98 |
| Pre-tax Income | 3,142 | 5,381 | 6,889 | 4,302 | 5,092 |
| Income Tax | 921 | 1,324 | 942 | 905 | 858 |
| Net Income Continuous | 2,222 | 4,057 | 5,947 | 3,397 | 4,234 |
| Minority Interests | -19 | -5 | -9 | -8 | 14 |
| Net Income | $2,241 | $4,062 | $5,956 | $3,405 | $4,220 |
| EPS Basic Total Ops | 0.08 | 0.14 | 0.21 | 0.12 | 0.16 |
| EPS Basic Continuous Ops | 0.07 | 0.14 | 0.21 | 0.12 | 0.16 |
| EPS Diluted Total Ops | 0.08 | 0.14 | 0.20 | 0.11 | 0.15 |
| EPS Diluted Continuous Ops | 0.08 | 0.14 | 0.19 | 0.11 | 0.14 |
| EBITDA(a) | $3,441 | $5,324 | $5,617 | $4,880 | $5,526 |